Skip to main content
Clinical Trials/NCT06214429
NCT06214429
Recruiting
Not Applicable

Evaluation of Atherosclerotic Carotid Plaque Stiffness by Shear Wave Elastography, Greyscale Median, Magnetic Resonance Imaging and Histopathological Analysis: Diagnostic Test Study

UPECLIN HC FM Botucatu Unesp1 site in 1 country43 target enrollmentMarch 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Carotid Atherosclerosis
Sponsor
UPECLIN HC FM Botucatu Unesp
Enrollment
43
Locations
1
Primary Endpoint
Plaque Stiffness
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The goal of this prospective diagnostic accuracy cohort study is to compare the accuracy of carotid atherosclerotic plaques stiffness assessed by shear wave elastography (SWE) with greyscale median values (GSM), magnetic resonance imaging (MRI) and histopathological findings in patients with carotid atherosclerotic plaques causing stenosis above 50%, symptomatic or not.

The main question it aims to answer is: is the plaque stiffness correlatable with GSM values, MRI findings or histopathological findings? Participants will be subjected to a vascular ultrasound study in which the SWE and GSM will be assessed. The second imaging modality for stenosis confirmation will be MRI and patients with confirmed symptomatic stenosis above 50% or assymptomatic stenosis above 70% will be considered for surgery intervention (endarterectomy or angioplasty). Patients that undergo endarterectomy will have the carotid plaques subjected to a histopathological study. The study will not arbitrate about the treatment decision.

Registry
clinicaltrials.gov
Start Date
March 1, 2023
End Date
December 31, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
UPECLIN HC FM Botucatu Unesp
Responsible Party
Principal Investigator
Principal Investigator

Matheus Bertanha, PhD

Professor

UPECLIN HC FM Botucatu Unesp

Eligibility Criteria

Inclusion Criteria

  • Patients with atherosclerotic carotid plaques that develop stenosis superior to 50%.

Exclusion Criteria

  • Previous cervical surgery;
  • Previous cervical radiotherapy;
  • Stenosis caused by vascular inflammatory diseases;
  • Pregnant women;
  • High carotid bifurcation (inaccessible by vascular ultrasound linear probe);
  • Posterior acoustic shadowing that impair morphological evaluation of the plaque.

Outcomes

Primary Outcomes

Plaque Stiffness

Time Frame: Through study completion, an average of 2 years.

Measured in kilopascal (kPa).

Plaque Greyscale

Time Frame: Through study completion, an average of 2 years.

Median value of plaque histogram.

Plaque Instability (MRI)

Time Frame: Through study completion, an average of 2 years.

Degree of plaque instability as proposed by American Heart Association (I to IV).

Plaque Instability (Histopathology)

Time Frame: If patient is submitted to carotid endarterectomy.

Degree of plaque instability as proposed by American Heart Association (I to IV).

Secondary Outcomes

  • Echolucent Plaque Area(Through study completion, an average of 2 years.)
  • Anatomic Site of Stenosis(Through study completion, an average of 2 years.)
  • Plaque Correlation with Arterial Wall(Through study completion, an average of 2 years.)
  • Fibrotic Cap(Through study completion, an average of 2 years.)
  • Peak Systolic Velocity(Through study completion, an average of 2 years.)
  • ECST Morphological Degree of Stenosis(Through study completion, an average of 2 years.)
  • End Diastolic Velocity(Through study completion, an average of 2 years.)
  • Velocity Ratio(Through study completion, an average of 2 years.)
  • Plaque Surface(Through study completion, an average of 2 years.)
  • Plaque Echogenicity(Through study completion, an average of 2 years.)
  • Ulceration(Through study completion, an average of 2 years.)
  • NASCET Morphological Degree of Stenosis(Through study completion, an average of 2 years.)

Study Sites (1)

Loading locations...

Similar Trials